BICYCLE THERAPEUTICS PLC Quarterly Debt-to-equity in % from Q1 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Bicycle Therapeutics Plc quarterly Debt-to-equity history and growth rate from Q1 2020 to Q3 2024.
  • Bicycle Therapeutics Plc Debt-to-equity for the quarter ending September 30, 2024 was 31.5 %, a 53.8% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 31.5 -36.6 -53.8% Sep 30, 2024
Q2 2024 40.7 -26.4 -39.3% Jun 30, 2024
Q1 2024 64 +11.3 +21.5% Mar 31, 2024
Q4 2023 69.3 +25.2 +57% Dec 31, 2023
Q3 2023 68 +26.9 +65.6% Sep 30, 2023
Q2 2023 67.1 +23.4 +53.3% Jun 30, 2023
Q1 2023 52.7 +6.45 +14% Mar 31, 2023
Q4 2022 44.2 -6.98 -13.6% Dec 31, 2022
Q3 2022 41.1 -21.1 -33.9% Sep 30, 2022
Q2 2022 43.8 -15.9 -26.6% Jun 30, 2022
Q1 2022 46.2 -14.9 -24.4% Mar 31, 2022
Q4 2021 51.2 -10.7 -17.3% Dec 31, 2021
Q3 2021 62.1 +13.6 +28% Sep 30, 2021
Q2 2021 59.7 +20.8 +53.5% Jun 30, 2021
Q1 2021 61.1 +32.6 +114% Mar 31, 2021
Q4 2020 61.8 Dec 31, 2020
Q3 2020 48.5 Sep 30, 2020
Q2 2020 38.9 Jun 30, 2020
Q1 2020 28.5 Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.